Look for:

Our offer for

MODERNA INC.


ISIN:
US60770K1079
WKN:
60770K107

2024/04/12 22:00:00
Price
105.14 USD
Difference -1.75% (-1.87)

General attributes

ISINUS60770K1079
SymbolMRNA
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)37,532 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)104.70 USD (300)
Ask (Ask size)105.14 USD (100)
Open106.00 USD
High107.88 USD
Low104.65 USD
Close (prev. day)107.01 USD
VWAP105.855475 USD
Volume (pcs)2,416,804
Trading volume255,846,886.74
Number of trades37,163
Last size-

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: MODERNA INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/04/12 22:00:00
Price
105.14 USD
Difference -1.75% (-1.87)

General attributes

ISINUS60770K1079
SymbolMRNA
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)37,532 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)104.70 USD (300)
Ask (Ask size)105.14 USD (100)
Open106.00 USD
High107.88 USD
Low104.65 USD
Close (prev. day)107.01 USD
VWAP105.855475 USD
Volume (pcs)2,416,804
Trading volume255,846,886.74
Number of trades37,163
Last size-

Performance and Risk

6m1Y3Y
Perf (%)+4.33%-32.41%-24.58%
Perf (abs.)+4.36-50.42-34.26
Beta1.411.041.28
Volatility57.0950.4066.27
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)107.20 USD (4,033,791)
Ø price 30 days | Ø volume 30 days (pcs.)104.40 USD (3,913,235)
Ø price 100 days | Ø volume 100 days (pcs.)96.35 USD (4,492,384)
Ø price 250 days | Ø volume 250 days (pcs.)105.52 USD (4,105,866)
YTD High | date115.97 USD (2024/01/08)
YTD Low | date84.06 USD (2024/02/13)
52 Weeks High | date163.24 USD (2023/04/14)
52 Weeks Low | date62.55 USD (2023/11/02)

All listings for MODERNA INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2024/04/1217:35100.08 EUR0.3281
Vienna Stock Exchange2024/04/1217:32100.22 EUR0.002
Tradegate2024/04/1222:2698.89 EUR0.5582
Stuttgart2024/04/1215:3198.50 EUR0.014
Nasdaq2024/04/1222:00105.14 USD255.8537,163
Munich2024/04/1221:1098.81 EUR0.012
London Stock Exchange European Trade Reporting2024/04/1217:30107.22 USD0.0013
Hanover2024/04/1208:0199.67 EUR0.003
Hamburg2024/04/1208:0199.67 EUR0.001
Frankfurt2024/04/1220:4499.00 EUR0.077
Euronext Milan MTF Trading After Hours2024/04/1118:00101.28 EUR0.001
Euronext Milan MTF Global Equity Market2024/04/1217:44100.36 EUR0.035
Duesseldorf2024/04/1219:3098.65 EUR0.007
Berlin2024/04/1220:2199.18 EUR0.0017
BX Swiss2024/04/1118:0095.441 CHF0.022

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=144067&ID_TYPE_IMAGE_LOGO=2

Contact Details

MODERNA INC.
- -
200 Technology Square - 02139 Cambridge
Telefon: +1-617-714-6500
Fax: +617-583-1998
E-mail: info@modernatx.com

PDF Downloads

Company report: MODERNA INC.PDF Download

Company Profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Members of Management Board

Noubar AfeyanChairman of Board of Directors
Elizabeth NabelMember of Board of Directors
Francois NaderMember of Board of Directors
Robert LangerMember of Board of Directors
Sandra HorningMember of Board of Directors
Elizabeth TallettMember of Board of Directors
Paul SaganMember of Board of Directors
Stephen BerensonMember of Board of Directors
Stéphane BancelChairman of Managing Board
Corinne Le GoffMember of Executive Committee
David MelineMember of Executive Committee
Juan AndresMember of Executive Committee
Kate CroninMember of Executive Committee
Marcello DamianiMember of Executive Committee
Paul Burton, M.D.Member of Executive Committee
Shannon Thyme KlingerMember of Executive Committee
Stephen Hoge, M.D.Member of Executive Committee
Tracey FranklinMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer